Autor:	Xiaoguang Zhen, J. P Gilbert, Thomas Voets, Rudi Vennekens, Debapriya Ghosh, Christopher M. Fanger, Wouter Everaerts, Timothy Strassmaier, Colleen Mcnamara, Joris Vriens, Magdalene M. Moran, Dirk De Ridder, Bernd Nilius, E Uykal, Fenqin Xue, Thomas Gevaert, Grzegorz Owsianik, Neil Hayward
Rok vydání:	2011
Předmět:	TRPV4 Cyclophosphamide business.industry Urology medicine Selective antagonist Pharmacology Bladder function business medicine.drug
Zdroj:	European Urology Supplements. 10:260
ISSN:	1569-9056
DOI:	10.1016/s1569-9056(11)60808-7
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::f67dd5bd1507c791b09a4f51cb7038ef https://doi.org/10.1016/s1569-9056(11)60808-7 Zobrazit plný text záznamu Full Text from ScienceDirect